glp-1 injections compounded semaglutide FDA alerts health care providers,

Ongoing Medical Support Your care doesn't stop at the prescription

However, medical professionals generally recommend baseline metabolic panels, thyroid function tests, and kidney function assessments before starting GLP-1 therapy

19 Another study by Wai and colleagues using a multi-institutional US database found greater risk of progression to PDR and DME in GLP-1RA users compared to SGLT-2I controls after propensity score matching for baseline characteristics

Prism software was used for statistical analysis and visualisation of data

Current FDA-approved uses for semaglutide include : Type 2 diabetes management (glycemic control) Cardiovascular risk reduction in type 2 diabetes with established CVD (Ozempic) Cardiovascular risk reduction in adults with established CVD and obesity/overweight (Wegovy) Chronic weight management in obesity or overweight with comorbidities Clinicians should prescribe semaglutide according to FDA-approved indications and established clinical guidelines, including those from the American Diabetes Association (ADA) and American College of Physicians (ACP)

3 Lincoff AM et al